Evidence map›Paper›PMID 34489875›Full record

ArticleFrontiers in microbiology2021

Antibiotic Resistance Profiles and Molecular Characteristics of Extended-Spectrum Beta-Lactamase (ESBL)-Producing

Gopalan Krishnan Sivaraman, Vineeth Rajan, Ardhra Vijayan, Ravikrishnan Elangovan, Alison Prendiville, Till T Bachmann

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 2 pooled it
3.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 2 syntheses or guidelines pooled it, 71 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Shiga Toxin-ProducingVeterinary sciences · 2026
    Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Observational
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Genomic insights into extended-spectrumJournal of medical microbiology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Gopalan Krishnan SivaramanMicrobiology, Fermentation and Biotechnology Division, ICAR-Central Institute of Fisheries Technology, Kochi, India.
Vineeth RajanMicrobiology, Fermentation and Biotechnology Division, ICAR-Central Institute of Fisheries Technology, Kochi, India.
Ardhra VijayanMicrobiology, Fermentation and Biotechnology Division, ICAR-Central Institute of Fisheries Technology, Kochi, India.
Ravikrishnan ElangovanDepartment of Biochemical Engineering and Biotechnology, Indian Institute of Technology Delhi, New Delhi, India.
Alison PrendivilleLondon College of Communication, University of the Arts London, London, United Kingdom.
Till T BachmannDivision of Infection and Pathway Medicine, Edinburgh Medical School, The University of Edinburgh, Edinburgh, United Kingdom.
Central Institute of Fisheries Technology · INIndian Institute of Technology Delhi · INUniversity of Edinburgh · GBUniversity of the Arts London · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study was undertaken to evaluate the prevalence of extended-spectrum beta-lactamase (ESBL)-producing

Indexed as

Escherichia coliextended-spectrum beta-lactamaseKlebsiella pneumoniaemultidrug resistanceshrimp aquaculture

Identifiers

PMID34489875
PMCPMC8417373
OpenAlexW3195980976

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.